IA
GILD icon

Invested Advisors’s Gilead Sciences GILD Stock Holding History

Invested Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Sell
3,024
-624
-17% -$82.2K 0.34% 84
2026
Q1 		$508K Sell
3,648
-959
-21% -$134K 0.51% 51
2025
Q4 		$565K Sell
4,607
-808
-15% -$98.2K 0.59% 39
2025
Q3 		$483K Buy
+5,415
New +$615K 0.7% 39

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Invested Advisors's GILD Position: Q2 2026 in Review

Invested Advisors reduced its Gilead Sciences (GILD) stake by 17% in Q2 2026, selling an estimated $82.2K and leaving 3,024 shares worth $382K. The position accounts for 0.34% of the portfolio, ranked #84.

Invested Advisors first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $565K in Q4 2025. 1,248 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Invested Advisors held 3,024 shares of Gilead Sciences worth $382K as of Q2 2026.
  • Invested Advisors sold 624 Gilead Sciences shares in Q2 2026, an estimated $82.2K.
  • Gilead Sciences made up 0.34% of Invested Advisors's portfolio in Q2 2026, its #84 holding.
  • Invested Advisors first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Invested Advisors's Gilead Sciences position peaked at $565K in Q4 2025.
  • 1,248 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.